Revolution Medicines Inc
RVMD
ISIN null / Valor 52143299
Revolution Medicines Inc
UMushroom community rating:
About company
Revolution Medicines is a clinical-stage biopharmaceutical company based in Redwood City, California, focused on discovering and developing small-molecule therapies that target the RAS/MAPK signaling pathway in cancer. The company pursues both direct inhibitors of oncogenic RAS mutants and agents that modulate RAS-dependent signaling nodes (for example, regulatory proteins upstream or downstream of RAS) using structure-guided and chemistry-driven approaches, and it advances multiple programs through preclinical and clinical development aimed at genetically defined tumor populations. Revolution Medicines operates within the precision oncology space, forming collaborations to support development and commercialization activities, and is publicly traded on the Nasdaq.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
27853 M
Market cap (USD)
2,790,639
Daily traded volume (Shares)
43.89 / 42.87
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Tilly Chapman
Atumush Roomabv
EQUITIES OF THE SAME SECTOR
